These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25848927)

  • 1. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.
    May MT; Justice AC; Birnie K; Ingle SM; Smit C; Smith C; Neau D; Guiguet M; Schwarze-Zander C; Moreno S; Guest JL; Monforte Ad; Tural C; Gill MJ; Bregenzer A; Kirk O; Saag M; Sterling TR; Crane HM; Sterne JA
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):348-54. PubMed ID: 25848927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
    Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
    AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
    Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
    Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
    Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
    J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.
    Weis N; Lindhardt BO; Kronborg G; Hansen AB; Laursen AL; Christensen PB; Nielsen H; Moller A; Sorensen HT; Obel N
    Clin Infect Dis; 2006 May; 42(10):1481-7. PubMed ID: 16619163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?
    Rancinan C; Neau D; Savès M; Lawson-Ayayi S; Bonnet F; Mercié P; Dupon M; Couzigou P; Dabis F; Chêne G;
    AIDS; 2002 Jul; 16(10):1357-62. PubMed ID: 12131212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Coinfection and Mortality in People Living with HIV in Middle Tennessee.
    Hall T; Jenkins CA; Hulgan T; Furukawa S; Turner M; Pratap S; Sterling TR; Tabatabai M; Berthaud V
    AIDS Res Hum Retroviruses; 2020 Mar; 36(3):193-199. PubMed ID: 31789047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.
    Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
    AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and progression of HIV disease.
    Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
    JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).
    Frederick T; Burian P; Terrault N; Cohen M; Augenbraun M; Young M; Seaberg E; Justman J; Levine AM; Mack WJ; Kovacs A
    AIDS Patient Care STDS; 2009 Nov; 23(11):915-23. PubMed ID: 19877800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort.
    Braitstein P; Justice A; Bangsberg DR; Yip B; Alfonso V; Schechter MT; Hogg RS; Montaner JS
    AIDS; 2006 Feb; 20(3):323-31. PubMed ID: 16439865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART.
    Lumbreras B; Jarrín I; del Amo J; Pérez-Hoyos S; Muga R; García-de la Hera M; Ferreros I; Sanvisens A; Hurtado I; Hernández-Aguado I
    AIDS; 2006 Jan; 20(1):111-6. PubMed ID: 16327326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
    Gebo KA; Diener-West M; Moore RD
    J Acquir Immune Defic Syndr; 2003 Oct; 34(2):165-73. PubMed ID: 14526205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Larsen CS; Jensen J; Obel N; Kronborg G
    Addiction; 2010 Mar; 105(3):529-35. PubMed ID: 20402997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.